Conjunctivitis in patients with atopic dermatitis treated with dupilumab
Atopic dermatitis (AD) is a common, chronic, inflammatory skin disorder with high physical and emotional burden. Robust evidence suggests that interleukin (IL)-4 and IL- 13 are key cytokines in the immunopathogenesis of AD. New emerging agents include dupilumab, a fully human monoclonal antibody dir...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BioExcel Publishing Ltd
2020-05-01
|
| Series: | Drugs in Context |
| Subjects: | |
| Online Access: | https://drugsincontext.com/conjunctivitis-in-patients-with-atopic-dermatitis-treated-with-dupilumab |